Literature DB >> 22055974

Presenilin enhancer-2 gene: identification of a novel promoter mutation in a patient with early-onset familial Alzheimer's disease.

Virginia Andreoli1, Francesca Trecroci, Antonella La Russa, Rita Cittadella, Maria Liguori, Patrizia Spadafora, Manuela Caracciolo, Gemma Di Palma, Carmela Colica, Antonio Gambardella, Aldo Quattrone.   

Abstract

UNLABELLED: γ-Secretase proteins complex cleaves the amyloid precursor protein (APP) to generate amyloid-β (Aβ) peptides. Considerable evidence suggests that alterations in genes encoding these proteins exert their influence on the pathogenesis of familial Alzheimer's disease (FAD). Presenilin enhancer-2 gene (PEN-2) is a necessary component of the γ-Secretase complex. Recently, it has been shown that PEN-2 mutations could be involved in Alzheimer's disease (AD). We performed a mutational screening of all PEN-2 coding and promoter regions in a FAD cohort derived from Southern Italy. Four hundred and fifty-two subjects (FAD: 97; CONTROLS: 355) were recruited for this study. We identified for the first time in a key region necessary for the promoter activity a novel 3 bp deletion in a subject with early-FAD. Our genetic data demonstrate that the mutant allele may influence the transcriptional activity of the PEN-2 gene. Although the effective role of the PEN-2 promoter deletion in AD is not entirely clear, these findings might lead to more studies on its functional and genetic role. Copyright Â
© 2011 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22055974     DOI: 10.1016/j.jalz.2011.02.010

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  5 in total

1.  Potential involvement of GRIN2B encoding the NMDA receptor subunit NR2B in the spectrum of Alzheimer's disease.

Authors:  Virginia Andreoli; Elvira Valeria De Marco; Francesca Trecroci; Rita Cittadella; Gemma Di Palma; Antonio Gambardella
Journal:  J Neural Transm (Vienna)       Date:  2013-12-01       Impact factor: 3.575

Review 2.  Clinical genetics of Alzheimer's disease.

Authors:  Zhangyu Zou; Changyun Liu; Chunhui Che; Huapin Huang
Journal:  Biomed Res Int       Date:  2014-05-13       Impact factor: 3.411

3.  ADAS-viewer: web-based application for integrative analysis of multi-omics data in Alzheimer's disease.

Authors:  Seonggyun Han; Jaehang Shin; Hyeim Jung; Jane Ryu; Habtamu Minassie; Kwangsik Nho; Insong Koh; Younghee Lee
Journal:  NPJ Syst Biol Appl       Date:  2021-03-19

4.  Immunological and prognostic analysis of PSENEN in low-grade gliomas: An immune infiltration-related prognostic biomarker.

Authors:  Kaijie Chen; Beibei Liang; Wenhao Ma; Guoqing Wan; Bing Chen; Changlian Lu; Yuzhou Luo; Xuefeng Gu
Journal:  Front Mol Neurosci       Date:  2022-07-28       Impact factor: 6.261

5.  Neuron-specific deletion of presenilin enhancer2 causes progressive astrogliosis and age-related neurodegeneration in the cortex independent of the Notch signaling.

Authors:  Hui-Ru Bi; Cui-Hua Zhou; Yi-Zhi Zhang; Xu-Dong Cai; Mu-Huo Ji; Jian-Jun Yang; Gui-Quan Chen; Yi-Min Hu
Journal:  CNS Neurosci Ther       Date:  2020-09-22       Impact factor: 5.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.